{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:58:46Z","timestamp":1794409126863,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Platinum resistance remains a major obstacle to effective treatment and improved prognosis in ovarian cancer. Although 5-methylcytosine (m\n                    <jats:sup>5<\/jats:sup>\n                    C) RNA modification has been implicated in chemoresistance, its precise functional role in ovarian cancer remains unclear. In this study, we integrated RNA-Seq and single-cell transcriptomic data from cisplatin-resistant ovarian cancer cell lines and patient samples, identifying the m\n                    <jats:sup>5<\/jats:sup>\n                    C reader protein ALYREF as a key regulator of platinum resistance. Functional studies using ALYREF and NSUN2 knockdown, overexpression, and mutant constructs\u2014combined with multi-omics analyses (RNA-Seq, m\n                    <jats:sup>5<\/jats:sup>\n                    C-BIS-Seq, and RIP-Seq)\u2014revealed that ALYREF binds to m\n                    <jats:sup>5<\/jats:sup>\n                    C-modified LGR4 mRNA, enhancing its stability and promoting activation of the Wnt\/\u03b2-catenin signaling pathway. Critically, this regulatory mechanism is dependent on NSUN2-mediated m\n                    <jats:sup>5<\/jats:sup>\n                    C modification of LGR4 mRNA. Together, our findings demonstrate that the NSUN2\/ALYREF\/LGR4 axis mediates platinum resistance through m\n                    <jats:sup>5<\/jats:sup>\n                    C-dependent stabilization of LGR4 and downstream Wnt signaling activation. Thus, targeting ALYREF may represent a promising strategy to overcome platinum resistance in ovarian cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08310-8","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:36:34Z","timestamp":1764905794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multi-omics analysis reveals that ALYREF-mediated m5C modification promotes platinum resistance in ovarian cancer via the NSUN2\/ALYREF\/LGR4 axis"],"prefix":"10.1038","volume":"17","author":[{"given":"Shimin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-0227","authenticated-orcid":false,"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"8310_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023;4:1239\u201357.","journal-title":"Nat Cancer"},{"key":"8310_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.annonc.2021.02.015","volume":"32","author":"T Baert","year":"2021","unstructured":"Baert T, Ferrero A, Sehouli J, O\u2019Donnell DM, Gonz\u00e1lez-Mart\u00edn A, Joly F, et al. The systemic treatment of recurrent ovarian cancer revisited. Ann Oncol. 2021;32:710\u201325.","journal-title":"Ann Oncol"},{"key":"8310_CR3","doi-asserted-by":"publisher","first-page":"e000026","DOI":"10.1136\/gocm-2024-000026","volume":"4","author":"A El-Agwany","year":"2024","unstructured":"El-Agwany A. Chemotherapy response assessment using ultrasound in ovarian cancer. Gynecology Obstet Clin Med. 2024;4:e000026.","journal-title":"Gynecology Obstet Clin Med"},{"key":"8310_CR4","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1158\/0008-5472.CAN-21-3819","volume":"82","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xie H, Chang X, Hu W, Li M, Li Y, et al. Single-cell dissection of the multiomic landscape of high-grade serous ovarian cancer. Cancer Res. 2022;82:3903\u201316.","journal-title":"Cancer Res"},{"key":"8310_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01263-w","volume":"20","author":"P Nombela","year":"2021","unstructured":"Nombela P, Miguel-L\u00f3pez B, Blanco S. The role of m(6)A, m(5)C and \u03a8 RNA modifications in cancer: novel therapeutic opportunities. Mol Cancer. 2021;20:18.","journal-title":"Mol Cancer"},{"key":"8310_CR6","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/cells9081758","volume":"9","author":"A Chellamuthu","year":"2020","unstructured":"Chellamuthu A, Gray SG. The RNA methyltransferase NSUN2 and its potential roles in cancer. Cells. 2020;9:1758.","journal-title":"Cells"},{"key":"8310_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12265-022-10336-8","volume":"16","author":"K Balachander","year":"2023","unstructured":"Balachander K, Priyadharsini JV, Roy A, Paramasivam A. Emerging role of RNA m5c modification in cardiovascular diseases. J Cardiovasc Transl Res. 2023;16:598\u2013605.","journal-title":"J Cardiovasc Transl Res"},{"key":"8310_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24969-x","volume":"12","author":"J Blaze","year":"2021","unstructured":"Blaze J, Navickas A, Phillips HL, Heissel S, Plaza-Jennings A, Miglani S, et al. Neuronal Nsun2 deficiency produces tRNA epitranscriptomic alterations and proteomic shifts impacting synaptic signaling and behavior. Nat Commun. 2021;12:4913.","journal-title":"Nat Commun"},{"key":"8310_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.807786","volume":"10","author":"J Xu","year":"2022","unstructured":"Xu J, Liu X, Chen Y, Wang Y, Liu T, Yi P. RNA 5-methylcytosine regulators contribute to metabolism heterogeneity and predict prognosis in ovarian cancer. Front Cell Dev Biol. 2022;10:807786.","journal-title":"Front Cell Dev Biol"},{"key":"8310_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05661-y","volume":"14","author":"N Wang","year":"2023","unstructured":"Wang N, Chen RX, Deng MH, Wei WS, Zhou ZH, Ning K, et al. m(5)C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6\/TK1 mRNAs splicing and stabilization. Cell Death Dis. 2023;14:139.","journal-title":"Cell Death Dis"},{"key":"8310_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7150\/ijbs.82316","volume":"20","author":"J Nulali","year":"2024","unstructured":"Nulali J, Zhang K, Long M, Wan Y, Liu Y, Zhang Q, et al. ALYREF-mediated RNA 5-methylcytosine modification promotes hepatocellular carcinoma progression via stabilizing EGFR mRNA and pSTAT3 activation. Int J Biol Sci. 2024;20:331\u201346.","journal-title":"Int J Biol Sci"},{"key":"8310_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06959-1","volume":"15","author":"Y Jin","year":"2024","unstructured":"Jin Y, Yao J, Fu J, Huang Q, Luo Y, You Y, et al. ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA. Cell Death Dis. 2024;15:578.","journal-title":"Cell Death Dis"},{"key":"8310_CR13","doi-asserted-by":"publisher","first-page":"9640","DOI":"10.1093\/nar\/gkx597","volume":"45","author":"M Shi","year":"2017","unstructured":"Shi M, Zhang H, Wu X, He Z, Wang L, Yin S, et al. ALYREF mainly binds to the 5\u2019 and the 3\u2019 regions of the mRNA in vivo. Nucleic Acids Res. 2017;45:9640\u201353.","journal-title":"Nucleic Acids Res"},{"key":"8310_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122372","volume":"338","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Xing C, Peng H. ALYREF (Aly\/REF export factor): a potential biomarker for predicting cancer occurrence and therapeutic efficacy. Life Sci. 2024;338:122372.","journal-title":"Life Sci"},{"key":"8310_CR15","doi-asserted-by":"publisher","first-page":"972341","DOI":"10.3389\/fendo.2022.972341","volume":"13","author":"P Zheng","year":"2022","unstructured":"Zheng P, Li N, Zhan X. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: novel prediction model of prognosis. Front Endocrinol. 2022;13:972341.","journal-title":"Front Endocrinol"},{"key":"8310_CR16","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.3390\/ijms21124272","volume":"21","author":"A McMellen","year":"2020","unstructured":"McMellen A, Woodruff ER, Corr BR, Bitler BG, Moroney MR. Wnt signaling in gynecologic malignancies. Int J Mol Sci.2020;21:4272.","journal-title":"Int J Mol Sci."},{"key":"8310_CR17","doi-asserted-by":"publisher","first-page":"23720","DOI":"10.18632\/oncotarget.4690","volume":"6","author":"AB Nagaraj","year":"2015","unstructured":"Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, et al. Critical role of Wnt\/\u03b2-catenin signaling in driving epithelial ovarian cancer platinum resistance. Oncotarget. 2015;6:23720\u201334.","journal-title":"Oncotarget"},{"key":"8310_CR18","doi-asserted-by":"publisher","first-page":"1597.","DOI":"10.3390\/genes15121597","volume":"15","author":"S Iluta","year":"2024","unstructured":"Iluta S, Nistor M, Buruiana S, Dima D. Wnt signaling pathway in tumor biology. Genes.2024;15:1597.","journal-title":"Genes."},{"key":"8310_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106191","volume":"145","author":"YKN Perumalsamy","year":"2022","unstructured":"Perumalsamy YKN, Warrier NK, Perumalsamy S, Dharmarajan LR. A. Wnt antagonist as therapeutic targets in ovarian cancer. Int J Biochem Cell Biol. 2022;145:106191.","journal-title":"Int J Biochem Cell Biol"},{"key":"8310_CR20","doi-asserted-by":"crossref","unstructured":"Targeting LGR4-Wnt activates ferroptosis and reverses drug resistance in colorectal cancer. Nat Cancer. 2024;5:542\u20133.","DOI":"10.1038\/s43018-023-00714-9"},{"key":"8310_CR21","doi-asserted-by":"publisher","first-page":"e0151089","DOI":"10.1371\/journal.pone.0151089","volume":"11","author":"W Chowanadisai","year":"2016","unstructured":"Chowanadisai W, Messerli SM, Miller DH, Medina JE, Hamilton JW, Messerli MA, et al. Cisplatin-resistant spheroids model clinically relevant survival mechanisms in ovarian tumors. PLoS ONE. 2016;11:e0151089.","journal-title":"PLoS ONE"},{"key":"8310_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2018.04.029","volume":"428","author":"Y Meng","year":"2018","unstructured":"Meng Y, Chen CW, Yung MMH, Sun W, Sun J, Li Z, et al. DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer. Cancer Lett. 2018;428:104\u201316.","journal-title":"Cancer Lett"},{"key":"8310_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"8310_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"8310_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"8310_CR26","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, et al. CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51:D870\u2013d6.","journal-title":"Nucleic Acids Res"},{"key":"8310_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"8310_CR28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"8310_CR29","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.","journal-title":"Innovation"},{"key":"8310_CR30","doi-asserted-by":"crossref","unstructured":"wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag. 2016.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"8310_CR31","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22:bbab260.","DOI":"10.1093\/bib\/bbab260"},{"key":"8310_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-3-r47","volume":"15","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox NJ, Huang RS. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol. 2014;15:R47.","journal-title":"Genome Biol"},{"key":"8310_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2263921","volume":"24","author":"S Yang","year":"2023","unstructured":"Yang S, Zhou D, Zhang C, Xiang J, Xi X. Function of m(5)C RNA methyltransferase NOP2 in high-grade serous ovarian cancer. Cancer Biol Ther. 2023;24:2263921.","journal-title":"Cancer Biol Ther"},{"key":"8310_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","volume":"11","author":"M Si","year":"2018","unstructured":"Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11:107.","journal-title":"J Hematol Oncol"},{"key":"8310_CR35","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zheng L, Shang W, Yang Z, Li T, Liu F, et al. Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death Differ. 2022;29:2190\u2013202.","journal-title":"Cell Death Differ"},{"key":"8310_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05547-5","volume":"14","author":"C Chi","year":"2023","unstructured":"Chi C, Hou W, Zhang Y, Chen J, Shen Z, Chen Y, et al. PDHB-AS suppresses cervical cancer progression and cisplatin resistance via inhibition on Wnt\/\u03b2-catenin pathway. Cell Death Dis. 2023;14:90.","journal-title":"Cell Death Dis"},{"key":"8310_CR37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41417-022-00574-y","volume":"30","author":"Z Song","year":"2023","unstructured":"Song Z, Liao C, Yao L, Xu X, Shen X, Tian S, et al. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt\/\u03b2-catenin signaling and autophagy via targeting HMGA2. Cancer Gene Ther. 2023;30:596\u2013607.","journal-title":"Cancer Gene Ther"},{"key":"8310_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01780-4","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wei J, Feng L, Li O, Huang L, Zhou S, et al. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer. 2023;22:81.","journal-title":"Mol Cancer"},{"key":"8310_CR39","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","volume":"35","author":"T Chen","year":"2023","unstructured":"Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, et al. NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35:1782\u201398.e8.","journal-title":"Cell Metab"},{"key":"8310_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s12276-024-01184-4","volume":"56","author":"X Liu","year":"2024","unstructured":"Liu X, Wei Q, Yang C, Zhao H, Xu J, Mobet Y, et al. RNA m(5)C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer. Exp Mol Med. 2024;56:600\u201315.","journal-title":"Exp Mol Med"},{"key":"8310_CR41","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53:D1670\u2013d6.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08310-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:25:22Z","timestamp":1769099122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08310-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8310"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08310-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}